Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression

NCT01131559 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped Sponsor halted study.

Conditions

Bipolar
Depression

Interventions

DRUG: Lisdexamfetamine
DRUG: Placebo control

Sponsor

Lindner Center of HOPE

Collaborators

[object Object]
[object Object]